Pro-death NMDA receptor signaling is promoted by the GluN2B C-terminus independently of Dapk1
Aberrant NMDA receptor (NMDAR) activity contributes to several neurological disorders, but direct antagonism is poorly tolerated therapeutically. The GluN2B cytoplasmic C-terminal domain (CTD) represents an alternative therapeutic target since it potentiates excitotoxic signaling. The key GluN2B CTD...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2017-07-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/17161 |